en

PRODUCT DETAIL

Enspryng 120 mg injekčný roztok v naplnenej injekčnej striekačke

Code 8485D
MA number EU/1/21/1559/002
Product Form: sol inj 3 (3x1)x1ml/120 mg (striek.inj.napl.polymér-multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AC Interleukin inhibitors
L04AC19 Satralizumab
Shelf life: 24
Container: pre-filled syringe
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 24.06.2021
Validity: 24.06.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.08.2021
eu-flag.png sk-flag.png